Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Weng LC et al. |
Association between use of FK506 and prevalence of post-transplantation diabetes mellitus in kidney transplant patients. |
2014 |
Transplant. Proc. |
pmid:24656004
|
Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Abou-Jaoude MM et al. |
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. |
2003 |
Transplant. Proc. |
pmid:14612103
|
Klintmalm GB et al. |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679828
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721261
|
Christians U et al. |
High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721262
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
|
Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings. |
1990 |
Transplant. Proc. |
pmid:1689897
|
Cadoff EM et al. |
Assay of FK 506 in plasma. |
1990 |
Transplant. Proc. |
pmid:1689898
|
Rahamimov R et al. |
Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. |
2003 |
Transplant. Proc. |
pmid:12644082
|
Sgrosso JL et al. |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. |
2002 |
Transplant. Proc. |
pmid:11959214
|
Gentil MA et al. |
Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15866631
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Garcia-Donaire JA et al. |
Tacrolimus as basic immunosuppression in pregnancy after renal transplantation. A single-center experience. |
2005 |
Transplant. Proc. |
pmid:16386528
|
Argudo A et al. |
Liver Transplant Patient Carriers of Polymorphism Cyp3a5*1 Donors May Need More Doses of Tacrolimus From the First Month After Transplantation. |
2015 |
Transplant. Proc. |
pmid:26518936
|
Sessa A et al. |
Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19460510
|
Armenta Bautista A et al. |
Renal Transplantation in Second-Level Private Hospitals in the State of Mexico. |
2018 |
Transplant. Proc. |
pmid:29579825
|
Tashiro H et al. |
Donor bone marrow perioperatively administered via portal vein induced prolongation of skin allograft survival and microchimerism in liver-transplanted rats. |
2000 |
Transplant. Proc. |
pmid:11120201
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Jurewicz WA |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report. |
1999 |
Transplant. Proc. |
pmid:10576048
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Ullman KS et al. |
Site of action of cyclosporine and FK 506 in the pathways of communication between the T-lymphocyte antigen receptor and the early activation genes. |
1991 |
Transplant. Proc. |
pmid:1721294
|
Schneeberger H et al. |
Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center. |
1998 |
Transplant. Proc. |
pmid:9636642
|
Yang S et al. |
Characteristics of long-term immunosuppressive therapy in Chinese pediatric renal transplant patients: a single-center experience. |
2009 |
Transplant. Proc. |
pmid:20005361
|
Hohage H et al. |
Cyclosporine and tacrolimus: influence on cardiovascular risk factors. |
2005 |
Transplant. Proc. |
pmid:15848615
|
Nassar CA et al. |
Effects of long-term FK 506 therapy on the alveolar bone and cementum of rats. |
2009 |
Transplant. Proc. |
pmid:19545747
|
Kurnatowska I et al. |
Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus. |
2011 |
Transplant. Proc. |
pmid:21996199
|
Gavlik A et al. |
Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up. |
1997 |
Transplant. Proc. |
pmid:9365633
|
Niederstadt C et al. |
Effect of FK506 on magnesium homeostasis after renal transplantation. |
1997 |
Transplant. Proc. |
pmid:9365709
|
Vischi S et al. |
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. |
1994 |
Transplant. Proc. |
pmid:7518143
|
Moscicka M et al. |
The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts. |
2003 |
Transplant. Proc. |
pmid:14529942
|
Ricordi C et al. |
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. |
1992 |
Transplant. Proc. |
pmid:1376512
|
Vargas V et al. |
Alpha-interferon for acute hepatitis C in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533374
|
Kim HC et al. |
Primary immunosuppression with tacrolimus in renal transplantation: a single center experience. |
2003 |
Transplant. Proc. |
pmid:12591370
|
Cooper MH et al. |
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. |
1991 |
Transplant. Proc. |
pmid:1721326
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Wilson C et al. |
Evaluation of daclizumab to reduce delayed graft function in non-heart-beating renal transplantation: a prospective, randomized trial. |
2005 |
Transplant. Proc. |
pmid:15919462
|
Weimer R et al. |
sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. |
2005 |
Transplant. Proc. |
pmid:15919463
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Aktürk S et al. |
Average Tacrolimus Trough Level in the First Month After Transplantation May Predict Acute Rejection. |
2017 |
Transplant. Proc. |
pmid:28340806
|
Fontana I et al. |
Severe rhabdomyolysis and acute renal failure in a kidney transplant patient treated with tacrolimus and chimaeric CD25 monoclonal antibody. |
2004 |
Transplant. Proc. |
pmid:15110640
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
Dahmen U et al. |
Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs. |
2002 |
Transplant. Proc. |
pmid:12270412
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Barten MJ et al. |
Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12270442
|
Nalesnik MA et al. |
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. |
1991 |
Transplant. Proc. |
pmid:1703335
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Busuttil RW and Holt CD |
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123119
|
Namieno T and Uchino J |
Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells. |
1996 |
Transplant. Proc. |
pmid:8908147
|
Marcus EA et al. |
Successful term pregnancy in an intestine-pancreas transplant recipient with chronic graft dysfunction and parenteral nutrition dependence: a case report. |
2015 |
Transplant. Proc. |
pmid:25724255
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
San Miguel C et al. |
Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital. |
2015 |
Transplant. Proc. |
pmid:26518930
|
Miura K et al. |
Development of the Intestinal Transplantation Model With Major Histocompatibility Complex Inbred CLAWN Miniature Swine. |
2016 |
Transplant. Proc. |
pmid:27320612
|
Ierardi E et al. |
Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. |
2001 |
Transplant. Proc. |
pmid:11377467
|
Jørgensen KA et al. |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176551
|
Castel MA et al. |
Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839245
|
Park JW et al. |
Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report. |
2011 Jul-Aug |
Transplant. Proc. |
pmid:21839284
|
Mor E et al. |
Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. |
2001 |
Transplant. Proc. |
pmid:11543802
|
Kokado Y et al. |
Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083515
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Matsumiya G et al. |
Serum interleukin-6 level after cardiac xenotransplantation in primates. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123586
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Maass E et al. |
Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report. |
2007 |
Transplant. Proc. |
pmid:18089410
|
Mabuchi M et al. |
Insulin-like growth factor-I enhances choleretic action of FK506 in rats. |
2003 |
Transplant. Proc. |
pmid:12826230
|
Boggs S et al. |
FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. |
1991 |
Transplant. Proc. |
pmid:1721420
|
Ogawa N et al. |
Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. |
1996 |
Transplant. Proc. |
pmid:8658710
|
Cooper MH et al. |
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721421
|
Yoshida Y et al. |
Effect of lipoprostaglandin E1 in concordant xenografts. |
1996 |
Transplant. Proc. |
pmid:8658716
|
McLaughlin GE et al. |
Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. |
2000 |
Transplant. Proc. |
pmid:10812158
|
Lo A et al. |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12742477
|
El-Sabrout R et al. |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176636
|
Wu M et al. |
Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267198
|
Koc-Zorawska E et al. |
Vascular adhesion protein-1, a novel molecule, in kidney and heart allograft recipients. |
2013 |
Transplant. Proc. |
pmid:23769096
|
Halloran PF et al. |
Calcineurin and the biological effect of cyclosporine and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9723430
|
Walgenbach KJ et al. |
Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. |
1998 |
Transplant. Proc. |
pmid:9745501
|
Ott R et al. |
Does conversion of immunosuppressive monotherapy from cyclosporine A to tacrolimus improve bone mineral density in long-term stable liver transplant recipients? |
2003 |
Transplant. Proc. |
pmid:14697971
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Kim YE and Eun SC |
Effect of FK506 ointment (Protopic) on rat skin allograft model. |
2014 |
Transplant. Proc. |
pmid:24815165
|
Sainsbury TS et al. |
Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata. |
1991 |
Transplant. Proc. |
pmid:1721453
|
Hirata Y et al. |
Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience. |
|
Transplant. Proc. |
pmid:29407332
|
Falconer SJ et al. |
Early or Late Conversion From Tac-BD to Tac-BD in Renal Transplantation: When is the Right Time? |
|
Transplant. Proc. |
pmid:26293044
|
Treede H et al. |
Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267444
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Umbro I et al. |
Long-term interleukin-2 assessment after conversion from a twice-daily to once-daily tacrolimus regimen in stable kidney recipients. |
2012 |
Transplant. Proc. |
pmid:22974867
|
Alagoz S et al. |
Gangliocytoma Presenting With Tacrolimus Neurotoxicity in a Renal Transplant Recipient: Case Report. |
2016 |
Transplant. Proc. |
pmid:27932167
|
Miyagawa S et al. |
Mechanism of unresponsiveness in rats induced by a short course of FK 506 or CyA. |
1991 |
Transplant. Proc. |
pmid:1703687
|
Deleuze S et al. |
New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine? |
2006 |
Transplant. Proc. |
pmid:16980075
|
Badiou S et al. |
Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? |
2006 |
Transplant. Proc. |
pmid:16980076
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|